ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,622Medicare Part D Prescriptions Filled, Including Refills

Rank: 143 out of 944

$595K Total Retail Price of All Prescriptions

Rank: 130 out of 944

423 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 423 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

18% of this provider’s 423 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 8,844 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
LISINOPRIL 411 364 1 3
HYDROCHLOROTHIAZIDE 411 382 1 9
SIMVASTATIN 384 365 3 1
HYDROCODONE-ACETAMINOPHEN 360 187 S3 4 10
PREDNISONE 322 276 5 32
LEVOTHYROXINE SODIUM 321 272 6 2
FUROSEMIDE 313 260 7 6
METHOTREXATE 267 231 8 129
WARFARIN SODIUM 259 254 9 7
OMEPRAZOLE 258 222 10 4
ATENOLOL 233 229 11 11
TRAMADOL HCL 220 195 12 21
POTASSIUM CHLORIDE 215 201 13 15
METOPROLOL TARTRATE 177 174 14 8
AMLODIPINE BESYLATE 164 149 15 5
METFORMIN HCL 161 140 16 12
CITALOPRAM HBR 147 142 17 19
GABAPENTIN 146 116 18 18
SERTRALINE HCL 136 131 19 23
HYDROXYCHLOROQUINE SULFATE 136 99 19 160
METOPROLOL SUCCINATE 129 116 21 14
FENTANYL 126 116 S2 22 57
LOSARTAN POTASSIUM 126 110 22 16
DONEPEZIL HCL 115 115 24 24
PRAVASTATIN SODIUM 111 109 25 17
NAMENDA 107 107 26 37
TRAZODONE HCL 104 73 27 45
ACETAMINOPHEN-CODEINE 102 63 S3 28 95
CELEBREX 98 62 29 110
PANTOPRAZOLE SODIUM 96 76 30 34
ATORVASTATIN CALCIUM 84 71 31 13
ALLOPURINOL 77 67 32 22
DIOVAN 75 75 33 38
ZOLPIDEM TARTRATE 74 49 34 25
MELOXICAM 72 57 35 68
GLIMEPIRIDE 69 66 36 47
CARVEDILOL 68 68 37 30
ALENDRONATE SODIUM 64 46 38 20
MORPHINE SULFATE ER 64 16 S2 38 80
CYCLOBENZAPRINE HCL 61 24 R 40 86
TAMSULOSIN HCL 57 51 41 27
CLOPIDOGREL 56 52 42 36
AMITRIPTYLINE HCL 56 41 R 42 79
POLYETHYLENE GLYCOL 3350 56 56 42 41
OXYCODONE HCL 56 37 S2 42 50
GLYBURIDE 53 49 R 46 63
PROAIR HFA 52 32 47 56
PAROXETINE HCL 52 43 47 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 31, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.